Nasdaq · CIK 0002028614
DMAA Drugs Made In America Acquisition Corp.
Insider trading from SEC Form 4. Last filing Feb 18, 2025.
Drugs Made In America Acquisition Corp. (DMAA) has 8 SEC Form 4 filings on file from 6 insiders, the latest filed on Feb 18, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Drugs Made In America Acquisition Corp., scored.
Transactions
Every row filed, 16 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Lynn Stockwell CEO and Exe. Chair of Board | POpen-market purchase Ordinary sharesindirect: See Footnotes | +30,000 | - | - | 4,188,780 | Feb 18, 2025 |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC owner | POpen-market purchase Ordinary shares | +30,000 | - | - | 4,188,780 | Feb 18, 2025 |
| Feb 18, 2025 | Lynn Stockwell CEO and Exe. Chair of Board | POpen-market purchase Rights to receive ordinary sharesderivativeindirect: See Footnotes | +30,000 | - | - | 430,000 | Feb 18, 2025 |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC owner | POpen-market purchase Rights to receive ordinary sharesderivative | +30,000 | - | - | 430,000 | Feb 18, 2025 |
| Jan 29, 2025 | Lynn Stockwell CEO and Executive COB | POpen-market purchase Ordinary sharesindirect: See footnote | +400,000 | - | - | 10,257 | Feb 4, 2025 |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC owner | POpen-market purchase Ordinary shares | +400,000 | - | - | 10,257,143 | Feb 4, 2025 |
| Jan 29, 2025 | Lynn Stockwell CEO and Executive COB | JOther Ordinary sharesindirect: See footnote | -400,000 | - | - | 9,857,143 | Feb 4, 2025 |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC owner | JOther Ordinary shares | -400,000 | - | - | 9,857,143 | Feb 4, 2025 |
| Jan 29, 2025 | Lynn Stockwell CEO and Executive COB | SOpen-market sale Ordinary sharesindirect: See footnote | -5,698,363 | - | - | 4,158,780 | Feb 4, 2025 |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC owner | SOpen-market sale Ordinary shares | -5,698,363 | - | - | 4,158,780 | Feb 4, 2025 |
| Jan 29, 2025 | Lynn Stockwell CEO and Executive COB | POpen-market purchase Rights to receive ordinary sharesderivativeindirect: See footnote | +400,000 | - | - | 400,000 | Feb 4, 2025 |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC owner | POpen-market purchase Rights to receive ordinary sharesderivative | +400,000 | - | - | 400,000 | Feb 4, 2025 |
| Jan 29, 2025 | Catherine Do director | JOther Ordinary shares | +100,000 | - | - | 100,000 | Feb 3, 2025 |
| Jan 29, 2025 | Glenn C. Worman CFO | JOther Ordinary shares | +100,000 | - | - | 100,000 | Feb 3, 2025 |
| Jan 29, 2025 | Sridhar G. Prasad director | JOther Ordinary shares | +100,000 | - | - | 100,000 | Feb 3, 2025 |
| Jan 29, 2025 | Myron W. Shulgan director | JOther Ordinary shares | +100,000 | - | - | 100,000 | Feb 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Catherine Dodirector
- Drugs Made In America Acquisition LLCowner
- Sridhar G. Prasaddirector
- Myron W. Shulgandirector
- Lynn StockwellCEO and Exe. Chair of Board
- Glenn C. WormanCFO
Questions about DMAA
Answered from the filings on this page, as of the latest one.
Are insiders buying DMAA?
No. In the last 90 days no insider at Drugs Made In America Acquisition Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade DMAA on the open market?
No open-market trade has been scored at Drugs Made In America Acquisition Corp.. The latest Form 4 on file was filed on Feb 18, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Drugs Made In America Acquisition Corp.?
6 people have filed a Form 4 at Drugs Made In America Acquisition Corp., among them Catherine Do (director), Drugs Made In America Acquisition LLC (10% owner), Sridhar G. Prasad (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.